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Introduction 
If accelerometer-based measurement of step count is to be incorporated into 
rehabilitation programmes for critical illness survivors, its validity must be determined. 
Two studies have investigated the validity of accelerometry to quantify step count in 
critical illness survivors, comparing accelerometer quantified step count to observed step 
count. (1,2) A mean difference of 0.92 steps (95% limits of agreement -3.27 - 5.11 steps) 
was determined for the ankle mounted AMP 331 accelerometer. (1) However, a thigh 
mounted activPAL accelerometer underestimated steps in hospitalised critical illness 
survivors, with a median (interquartile range) absolute percentage error for total step 
count of 70.1% (28.6%). (2)  
Other ankle mounted accelerometers, such as the Actigraph GT3X+ have 
demonstrated validity in quantification of step count in hospitalised elderly populations 
who walk at slow speeds, when the low frequency extension data filter is activated. (3) 
When this filter is activated, sensitivity of the accelerometer to low intensity movements 
is increased. (4) The validity of any Actigraph accelerometer model to quantify step 
count within populations recovering from critical illness has not undergone investigation.   
This study aimed to investigate the validity of the Actigraph GT3X accelerometer, 
in quantification of step count during self-selected distances and walking speeds in ward 
based hospitalised adults recovering from critical illness.  
Methods 
The study was prospective and observational and registered on the database 
ClinicalTrials.gov (NCT03295630). Participants were recruited consecutively from 
September 2016 to April 2017, within a large NHS teaching hospitals Trust.  The study 
was conducted on the ward they were admitted to following discharge from the intensive 
care unit.  Ethical approval was granted from the East Midlands NHS Research Ethics 
Committee (REF: 16/EM/0210/198965) and York St John University Research Ethics 
Committee (REF: 129091178_Anderson_15052016).  
Adults aged 18 years or over who had required greater than 48 hours of 
mechanical ventilation and able to mobilise independently or with assistance of one 
person or a walking aid were eligible to take part. Participants were included if they could 
understand the study information sheet and provide written, informed consent. 
Participants were excluded if they were unwilling to wear the accelerometers for three 
hours or if they refused to be observed throughout this period. 
A semi-structured movement protocol was performed, not exceeding three hours 
duration, involving supine and side lying, postural transfers, periods of time spent sitting 
in a chair and walking self-selected distances. The activities could be completed in any 
order, with rests as needed.  
Participants wore two tri-axial Actigraph GT3X accelerometers (Actigraph LLC, 
Pensacola, Florida, USA); each measuring 3.8 x 3.7 x 1.8cm; weighing 27g. The low 
frequency extension data filter was activated on both accelerometers to increase 
sensitivity to low intensity movement. (3,4) Single patient use broad elasticised bands 
secured with Velcro were utilised as a method of attachment. One accelerometer was 
positioned on the anteromedial thigh, the other on the lateral aspect of the ankle (above 
the lateral malleolus). The non-dominant leg was chosen based on recommendations of 
manufacturers of other lower limb mounted models which quantify physical activity. (5) 
Thigh and ankle placement sites have previously undergone investigation of their validity 
in quantification of step count in both acutely hospitalised older adults and critical illness 
survivors. (1-3, 6,7)   
When participants undertook the walking aspect of the protocol, a single observer 
(the chief investigator) walked with them, counting their steps until participants decided 
to stop.  The duration of the walk was noted to the second, using a Precision™ radio-
controlled alarm clock (Model AP004: Peers Hardy Group, Solihull). Time 
synchronization was achieved between the accelerometers and the clock by ensuring that 
the time on the clock was identical to that on the laptop computer used to programme the 
accelerometers to capture step count.  Observed step count was compared to step count 
data captured by the ankle and thigh mounted accelerometers for the identical time 
stamped periods.  
Bland Altman analysis was used to determine agreement between observed step 
count and accelerometer quantified step count. (8)  Mean differences (95% limits of 
agreement) were calculated for both the thigh and ankle placement to understand if there 
was a superior placement site. Absolute percentage error between accelerometer 
quantified step count and observed step count was calculated, using the formula: 
(accelerometer data for step count – observed data for step count) / observed data for step 
count x 100, for both the ankle and thigh placements.  This formula was previously used 
in another study investigating the validity of a thigh mounted accelerometer (activPAL) 
to quantify step count within acutely hospitalised older and stroke populations. (7)   
An intraclass correlation coefficient analysis was undertaken (two-way random, 
absolute agreement) to evaluate intermethod reliability between accelerometer quantified 
step count and observed step count. (9) Calculation of the 95% confidence interval was 
also undertaken as part of this analysis.  All statistical analyses were undertaken using the 
International Business Machines, Statistical Package for the Social Sciences (IBM SPSS), 
version 20.   
Results  
Twenty-four hospitalised adults were invited to take part in the study.  Four patients 
declined participation. Of these, one participant was already enrolled in other study and 
three did not feel physically ready to undertake aspects of the semi-structured movement 
protocol. Twenty patients (age: mean 62.3, SD 11.5) provided written, informed consent to 
participate. Some participants could mobilise independently (n = 6), others used a wheeled 
walking frame (n = 5), a single walking stick (n = 4), hand held assistance of one person (n = 
3), a three wheeled walking frame (n = 1) or two Fischer sticks (n = 1). Table 1 presents the 
demographic data for all hospitalised adults who consented and participated.   
 
Table 1 Demographic data for the study population to go here    
 
Thirty-one separate walking episodes were analysed as some participants chose to 
undertake a second walk. A mean (SD) of 45.87 (± 19.72) steps was calculated for 
observed step count (range 15 - 90).  Table 2 details the results of Bland Altman analysis 
for agreement between accelerometer quantified step count and observed step count for the 
isolated ankle and thigh placements. The results of correlational analysis are also detailed in 
Table 2.  
 
Table 2 Results of Bland Altman and correlational analysis for the ankle and thigh 
 accelerometer placement sites to go here   
 
Accelerometer quantified step count for the ankle placement was superior to the 
thigh. These findings were demonstrated in the mean differences and 95% limits of 
agreement for both placement sites. The ankle placement was strongly correlated with 
observational step count. (9) A moderate correlation was determined for the thigh placement; 
however, the range of values calculated for the 95% confidence interval was wide (-0.10 - 
0.78).  
Figures 1 and 2 present the scatterplots created during Bland Altman analysis 
comparing ankle and thigh accelerometer quantified step count against observed step count. 
The scatterplot in Figure 2 demonstrates how the thigh placement regularly undercounted 
steps.  
 
Figures 1 and 2 Scatterplots for mean difference (95% limits of agreement) for ankle 
and thigh accelerometer placement sites to go here 
 
The median absolute percentage error (interquartile range) for quantification of step count for 
the ankle placement was 2.4%, (5.3, 0). The absolute percentage error (interquartile range) 
for the thigh placement was considerably higher at 42.4% (50, 27), with a much greater level 
of undercounting of steps compared to the ankle.  The greatest absolute percentage error for 
the thigh placement was 54%, where a walk was performed with a wheeled walking frame. 
The smallest absolute percentage error was 0% for the thigh, where the accelerometer 
recorded an identical number of steps compared to observed step count. However, an 
absolute percentage error of 42% was calculated for a second walk taken by the same 
participant, suggesting the thigh placement was not quantifying steps consistently.  
Following removal of the accelerometers and skin examination there were no 
incidences of pallor, non-blanching redness or significant indentation attributable to wearing 
the accelerometers.  
 
Discussion 
This study determined that an ankle mounted Actigraph GT3X accelerometer, with the 
low frequency extension filter activated, was valid in step count quantification in 
hospitalised adults recovering from critical illness. When positioned on the thigh, the 
Actigraph GT3X underestimated steps on almost all walks. This finding concurs with 
other studies which have investigated the validity of a thigh mounted accelerometer 
(activPAL) in quantification of step count in critical care survivors, hospitalised older 
adults, patients with advanced cancer (in and outpatient) and outpatients with rheumatoid 
arthritis. (2,7,10,11) Absolute percentage error was reduced when the accelerometer was 
mounted on the non-affected limb in hospitalised acute stroke patients and community-
based patients post hip fracture. (7)   
The excellent results found for the ankle mounted GT3X concur with a study by 
Edbrooke et al. (2012), who investigated the validity of the ankle mounted AMP 331 
accelerometer in hospitalised adults recovering from critical illness. (1)   A mean 
difference (95% limits of agreement) of 0.92 (-3.27 to 5.11) steps was found when 
compared to observed step count. (1)  This compares favourably with the results reported 
from this study, where a mean difference of - 0.84 (-3.88 to 2.2 steps) was calculated.  
Furthermore, correlational analyses revealed identical results, with both studies reporting 
an intraclass correlation coefficient (95% confidence interval) of 0.99 (0.99-1.0) for the 
ankle. These findings suggest excellent intermethod reliability for this placement site 
which are not confined to one accelerometer model.   
Similar results for an ankle placement have been reported for older hospitalised 
adults, using the GT3X+ accelerometer. (3) When the low frequency extension data filter 
was activated an intraclass correlation (95% confidence interval) of 0.94 (0.87-0.97) was 
determined. When the low frequency extension was deactivated, an intraclass correlation 
(95% confidence interval) of 0.68 (-0.21-0.9) was reported for the same placement site. 
(3) This finding supports activation of the low frequency extension data filter within 
Actigraph models to improve the accuracy of step count quantification within 
hospitalised populations who are likely to walk at slower speeds, due to its increased 
sensitivity to low intensity movement. (4)   
The ankle mounted AMP 331 accelerometer was used to quantify physical 
activity levels in critical illness survivors. (12) The fair correlation between average 
number of steps recorded per day compared against self-report (r = 0.33, p = 0.05) may 
have been as a result of poor estimation of self-reported activity levels. (13) Critical 
illness survivors may experience persistent cognitive impairment, (14) which could 
adversely impact on the ability to recall all activity undertaken. The use of more objective 
methods of activity monitoring may provide a solution to accurately monitor activity 
levels. The setting of personalized, daily target step count goals may prove to be a 
motivator, exerting positive effects on activity levels during admission and following 
discharge from hospital.      
This study has some limitations. Observation of steps counted by a single 
observer served as the criterion measure for which accelerometer step count was 
compared. Video recording was not used due to the risk of unintentionally capturing 
footage of participants or other patients within the hospital ward, posing ethical concerns. 
Whilst every effort was made to count every step taken by patients during walking 
episodes, it is possible that errors may have occurred. Walking episodes could not be 
revisited to clarify whether observed step count had been accurately recorded. The use of 
video recording would also have permitted a second observer to agree the number of 
steps taken by participants during each individual walk.  
Participants self-selected the distances and speed that they walked. It was not 
possible to calculate walking speed to understand if there may have been a threshold 
walking speed which may have improved the ability of the thigh mounted Actigraph 
GT3X. Efforts were made to make the semi-structured movement protocol as naturalistic 
as possible. Introduction of pre-determined set distances to walk in order to assist in  
calculation of walking speed would possibly have made patients walk further than they 
felt they could physically achieve, which may have posed ethical concerns.  
This study enrolled patients with no cognitive impairment. It remains unclear how 
acceptable an ankle placement would be with patients experiencing persistent cognitive 
impairment following critical illness. Another study conducted within a hospital inpatient 
population experiencing delirium, did not encounter incidences of premature removal by 
participants when multiple accelerometers were mounted on the lower limb. (15) Further 
research is encouraged to ascertain the acceptability of the ankle placement within those 
experiencing varying degrees of cognitive impairment following critical illness.  
Accelerometer validity was investigated in a small sample size (n = 20), under 
limited conditions within a hospital ward setting. Walking was not undertaken on uneven 
ground or outside, which limits generalisability of the findings to all environments. 
Further research is encouraged within this patient group, enrolling much larger sample 
sizes, to continue validity investigation of accelerometers to quantify step count within 
the wider environment, incorporating outdoor and uneven surfaces. Placement sites other 
than the ankle should be explored, such as the wrist, increasing the options for placement 
should they demonstrate validity.  
An implication of such investigations is that placement sites which have 
demonstrated validity could function as criterion measures during the development of 
bespoke smartphone applications which incorporate step count quantification, to provide 
feedback and monitor improvements in activity levels. Investigation into comfort should 
form part of these investigations to understand if wearing accelerometers for prolonged 
periods (i.e. during the entirety of waking hours) pose any tissue viability concerns or 
adversely affect compliance in wearing them.     
Clinical Messages 
● Step count quantified by an ankle mounted Actigraph GT3X accelerometer 
demonstrates concordance with observed step count within ward-based adults 
recovering from critical illness.  
● Activation of the low frequency extension filter is recommended to increase 
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Table 1 Demographic data for the study population    
 
Characteristic  Mean ± SD (range), median (IQR) or 
n (%)  
 
Age (years)  
 
62.3 ± 11.5 (39 - 82)  
 
Male: Female  13 (65%): 7 (35%)  
 
BMI  25.9 ± 6.1 (16.9 – 38.3) 
  
Ventilation period (days)  15.0 (5.50, 36.0)  
 
ICU LOS (days)  21.0 (8.25, 42.75)  
 
Hospital LOS (days)  35 (17.25, 64.75)  
 
 
BMI, Body Mass Index    SD, Standard deviation    IQR, Interquartile range   LOS, 






Table 2 Results of Bland Altman and correlational analysis for the ankle and thigh 




Mean difference (95% limits of 
agreement) 
 




-0.84 steps (-3.88 to 2.2 steps) 
  
0.99 (0.99 - 1.0) 
Thigh -17.7 steps (-40.63 to 5.23) 0.46 (-0.10 - 0.78). 
 





























LOA, limits of agreement 
 
 
 
 
 
 
 
 
 
